To test if A2058 metastatic melanoma cells interact with endothelial cells through VLA-4/VCAM-1 binding, we pre-treated A2058 cells with neutralizing antibodies against the VLA-4 receptors and immediately cultured them in direct contact with endothelial cells to assess gap formation. Here, VCAM1 is linked to melanoma.